 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Aug 29, 2023 |
| Title |
Cooperative armoring of CAR and TCR T-cells by T cell-restricted IL-15 and IL-21 universally enhances solid tumor efficacy |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Chimeric antigen receptor (CAR) and T-cell receptor (TCR) T-cell therapies are effective in a subset of patients with solid tumors, but new approaches are needed to enhance efficacy and universally improve patient outcomes. IL-15 and IL-21 are common cytokine-receptor gamma chain family members with distinct, pleiotropic effects on T-cells and other lymphocytes. We found that self-delivery of these cytokines by CAR or TCR T-cells prevents functional exhaustion by repeated stimulation and limits the emergence of dysfunctional natural killer (NK)-like T-cells. Across different preclinical murine solid tumor models, we observe enhanced regression with each individual cytokine but the greatest anti-tumor efficacy when T-cells are armored with both. Thus, the co-expression of membrane-tethered IL-15 and IL-21 represents a technology to enhance the resilience and function of engineered T-cells against solid tumors and could be applicable to multiple therapy platforms and diseases.
|
| |
|
| Overall design |
T cells from a 28-year-old donor were transduced to express E7-TCR (E7-TCR T cells). We compare E7-TCR T cells with either 1. Tethered IL15 or 2. Tethered IL15/IL21. These T cells were then exposed to continuous antigen (CAE) via CaSki cancer cells in vitro. Cancer cells were replenished Q2-4 days for a total of 14 tumor rechallenges. The samples were analyzed after manufacturing (no tumor exposure, Day0), after 5 exposures (Day12), and after 14 exposured (Day26) using single-cell sequencing. In each sample, we labeled the IL15 cells with TotalSeq-C0251, cat. no. 394661, barcode seq. GTCAACTCTTTAGCG; - IL15/21 cells TotalSeq-C0252, cat. no. 394663, barcode seq. TGATGGCCTATTGGG
|
| |
|
| Contributor(s) |
Nguyen R, Zhang X |
| Citation(s) |
37910044 |
| Submission date |
Apr 13, 2023 |
| Last update date |
Nov 28, 2023 |
| Contact name |
Xiyuan Zhang |
| E-mail(s) |
xiyuan.zhang@nih.gov
|
| Phone |
240-858-3835
|
| Organization name |
National Cancer Institute
|
| Department |
Pediatric Oncology Branch
|
| Street address |
10 Center Drive
|
| City |
Bethesda |
| State/province |
MD |
| ZIP/Postal code |
20892 |
| Country |
USA |
| |
|
| Platforms (1) |
|
| Samples (3) |
|
| Relations |
| BioProject |
PRJNA955221 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE229651_RAW.tar |
113.9 Mb |
(http)(custom) |
TAR (of H5) |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
|
|
|
|
 |
